COMBINATION CHEMO-IMMUNOTHERAPY OF METASTATIC BREAST-CANCER WITH 5-FLUOROURACIL, ADRIAMYCIN, CYCLOPHOSPHAMIDE, AND BCG

被引：0
|
作者：
HORTOBAGYI, GN
GUTTERMAN, JU
BLUMENSCHEIN, GR
TASHIMA, CK
BURGESS, MA
EINHORN, L
BUZDAR, AU
RICHMAN, SP
HERSH, EM
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT DEV THERAPEUT,HOUSTON,TX 77030
[2] INDIANA UNIV,DEPT MED,INDIANAPOLIS,IN 46204
来源：
CANCER | 1979年 / 44卷 / 05期
关键词：
D O I：
10.1002/1097-0142(197911)44:5<1955::AID-CNCR2820440559>3.0.CO;2-P
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1955 / 1962
页数：8
相关论文
共 50 条
  • [21] A COMPARISON OF CYCLOPHOSPHAMIDE, ADRIAMYCIN, AND 5-FLUOROURACIL (CAF) AND CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL, VINCRISTINE, AND PREDNISONE (CMFVP) IN PATIENTS WITH ADVANCED BREAST-CANCER
    SMALLEY, RV
    LEFANTE, J
    BARTOLUCCI, A
    CARPENTER, J
    VOGEL, C
    KRAUSS, S
    BREAST CANCER RESEARCH AND TREATMENT, 1983, 3 (02) : 209 - 220
  • [22] COMBINATION CHEMO-IMMUNOTHERAPY FOR ADVANCED RENAL-CARCINOMA WITH ADRIAMYCIN, BLEOMYCIN, VINCRISTINE, CYCLOPHOSPHAMIDE, PLUS BCG
    DANA, BW
    ALBERTS, DA
    CANCER CLINICAL TRIALS, 1981, 4 (02) : 205 - 207
  • [23] A PHASE-III RANDOMIZED TRIAL OC CYCLOPHOSPHAMIDE, MITOXANTRONE, AND 5-FLUOROURACIL (CNF) VERSUS CYCLOPHOSPHAMIDE, ADRIAMYCIN, AND 5-FLUOROURACIL (CAF) IN PATIENTS WITH METASTATIC BREAST-CANCER
    ALONSO, MC
    TABERNERO, JM
    OJEDA, B
    LLANOS, M
    SOLA, C
    CLIMENT, MA
    SEGUI, MA
    LOPEZ, JJ
    BREAST CANCER RESEARCH AND TREATMENT, 1995, 34 (01) : 15 - 24
  • [24] COMPARISON OF ADRIAMYCIN COMBINATION DRUG PROGRAM WITH BCG IMMUNOTHERAPY VS MER IMMUNOTHERAPY FOR METASTATIC BREAST-CANCER
    TASHIMA, CK
    BLUMENSCHEIN, GR
    GUTTERMAN, JU
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 288 - 288
  • [25] ADJUVANT CHEMO-IMMUNOTHERAPY IN BREAST-CANCER
    JORGENSEN, OG
    GUNDERSEN, S
    ACTA CHIRURGICA SCANDINAVICA, 1981, : 109 - 109
  • [26] COMPARISON OF CYCLOPHOSPHAMIDE, ADRIAMYCIN, 5-FLUOROURACIL (CAF) AND CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL, VINCRISTINE, PREDNISONE (CMFVP) IN PATIENTS WITH METASTATIC BREAST-CANCER - SOUTHEASTERN CANCER STUDY-GROUP PROJECT
    SMALLEY, RV
    CARPENTER, J
    BARTOLUCCI, A
    VOGEL, C
    KRAUSS, S
    CANCER, 1977, 40 (02) : 625 - 632
  • [27] MITOXANTRONE, CYCLOPHOSPHAMIDE, AND 5-FLUOROURACIL IN THE TREATMENT OF HORMONALLY UNRESPONSIVE METASTATIC BREAST-CANCER
    HOLMES, FA
    YAP, HY
    ESPARZA, L
    BUZDAR, AU
    HORTOBAGYI, GN
    BLUMENSCHEIN, GR
    SEMINARS IN ONCOLOGY, 1984, 11 (03) : 28 - 31
  • [28] TREATMENT OF METASTATIC BREAST-CANCER WITH THE COMBINATION OF IFOSFAMIDE, EPIRUBICIN AND 5-FLUOROURACIL
    GHAVAMZADEH, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 : S66 - S68
  • [29] PROGNOSTIC FACTORS (PF) IN METASTATIC BREAST-CANCER (MBC) TREATED WITH COMBINATION CHEMO-IMMUNOTHERAPY (CI)
    SWENERTON, KD
    LEGHA, SS
    HORTOBAGYI, GN
    GUTTERMAN, JU
    GEHAN, EA
    BLUMENSCHEIN, GR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 371 - 371
  • [30] CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL, ALTERNATING WITH ADRIAMYCIN AND MITOMYCIN-C IN METASTATIC BREAST-CANCER - A PILOT-STUDY
    CRUCIANI, G
    TIENGHI, A
    MOLINARI, AL
    FIORENTINI, G
    ROSTI, G
    TURCI, D
    MARANGOLO, M
    TUMORI, 1987, 73 (03) : 303 - 307
12345